Stay updated on Lintuzumab in CLAG-M for AML Clinical Trial
Sign up to get notified when there's something new on the Lintuzumab in CLAG-M for AML Clinical Trial page.

Latest updates to the Lintuzumab in CLAG-M for AML Clinical Trial page
- Check6 days agoChange DetectedRevision tag updated from v3.5.3 to v3.5.4 in the page history, indicating a new version of the study record history. This update changes only the metadata shown on the page and does not modify the underlying data or user-facing content.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision label updated from v3.5.2 to v3.5.3 on the page history, indicating a new maintenance release. This change does not modify study details or results presented on the page.SummaryDifference0.2%

- Check27 days agoChange DetectedNo changes were detected in the provided additions/deletions for this page.SummaryDifference0.1%

- Check34 days agoChange DetectedThe page history adds a new revision entry v3.5.2 and removes the older revision v3.5.0 from the list.SummaryDifference0.1%

- Check63 days agoChange DetectedRevision history updated to add version 3.5.0 and remove version 3.4.3.SummaryDifference0.1%

- Check70 days agoChange DetectedAdded Revision: v3.4.3 to the record history and removed Revision: v3.4.2.SummaryDifference0.1%

Stay in the know with updates to Lintuzumab in CLAG-M for AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lintuzumab in CLAG-M for AML Clinical Trial page.